Ashley N. Krepline - Concepedia

Author

Ashley N. Krepline

Medical College of Wisconsin ORCID

Also Known As

A.N. Krepline, Ashley Krepline, Ashley N Krepline, Ashley N. Krepline

Publications

561

Citations

H-Index

Concepts

All Affiliations

Medical College of Wisconsin

About

Ashley N. Krepline is an author at Medical College of Wisconsin specializing in medicine, surgical oncology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	282
2	Diabetes	1	1	10
3	Gastroenterology	1	1	10
4	Geriatrics	1	1	11
5	Hepatology	1	1	47

Ashley N. Krepline

Publications

528

Citations

H-Index

Page 1

	Year	Citations
Importance of Normalization of CA19-9 Levels Following Neoadjuvant Therapy in Patients With Localized Pancreatic Cancer Susan Tsai, Ben George, D. Wittmann, Annals of Surgery	2018	216
Adjuvant therapy rates and overall survival in patients with localized pancreatic cancer from high Area Deprivation Index neighborhoods Javier Mora, Ashley N. Krepline, Mohammed Aldakkak, The American Journal of Surgery Surgical OncologyOncologyPancreatic CancerOverall SurvivalGastrointestinal Oncology	2020	74
Pre-treatment carbohydrate antigen 19-9 does not predict the response to neoadjuvant therapy in patients with localized pancreatic cancer Mohammed Aldakkak, Kathleen K. Christians, Ashley N. Krepline, HPB Surgical OncologyPancreatic CancerNeoadjuvant TherapyGastrointestinal OncologyLocalized Pancreatic Cancer	2015	68
Patency Rates of Portal Vein/Superior Mesenteric Vein Reconstruction After Pancreatectomy for Pancreatic Cancer Ashley N. Krepline, Kathleen K. Christians, Kaleb D Duelge, Journal of Gastrointestinal Surgery Surgical OncologyPancreatic CancerHepatologyPancreatic Fluid CollectionMedicine	2014	47
Use of neoadjuvant therapy in patients 75 years of age and older with pancreatic cancer John T. Miura, Ashley N. Krepline, Ben George, Surgery Surgical OncologyOncologyPancreatic CancerNeoadjuvant TherapyGastrointestinal Oncology	2015	41
Is Adjuvant Therapy Necessary for All Patients with Localized Pancreatic Cancer Who Have Received Neoadjuvant Therapy? Chad A. Barnes, Ashley N. Krepline, Mohammed Aldakkak, Journal of Gastrointestinal Surgery Surgical OncologyPancreatic CancerNeoadjuvant TherapyGastrointestinal OncologyMedicine	2017	31
Venous thromboembolism prophylaxis during neoadjuvant therapy for resectable and borderline resectable pancreatic cancer-Is it indicated? Ashley N. Krepline, Kathleen K. Christians, Ben George, Journal of Surgical Oncology	2016	30
Neoadjuvant therapy for pancreatic cancer in patients older than age 75. John T. Miura, Ashley N. Krepline, Kaleb D Duelge, Journal of Clinical Oncology Surgical OncologyNeoadjuvant TherapyCancer ManagementPrognosisPathology	2014	11
Poor Glycemic Control Is Associated with Failure to Complete Neoadjuvant Therapy and Surgery in Patients with Localized Pancreatic Cancer E.S. Paul Rajamanickam, Kathleen K. Christians, Mohammed Aldakkak, Journal of Gastrointestinal Surgery Diabetes ManagementSurgical OncologyOncologyPancreatic CancerGastrointestinal Oncology	2016	10

Page 1